Tilray Brands, Inc. (TLRY) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Earnings Reports
-
TILRAY (TLRY) Q4 2026: International Revenue Hits $700M Run Rate, Driving Global Platform Leverage
July 29, 2026
-
Tilray (TLRY) Q3 2026: International Cannabis Revenue Jumps 73%, Driving Platform Leverage
June 16, 2026
-
TILRAY (TLRY) Q1 2026: Cannabis Revenue Hits $65M as International Permits Unlock New Market Reach
June 16, 2026
-
TILRAY (TLRY) Q4 2025: International Cannabis Revenue Jumps 71% as Margin Focus Reshapes Portfolio
June 16, 2026
-
TILRAY (TLRY) Q2 2026: International Cannabis Revenue Jumps 36% as Global Expansion Accelerates
June 15, 2026